Journa has introduced Bondia, a daily synbiotic medical food formulated to support bone health and slow bone loss associated with menopause, weight, and aging. The product is now available for purchase through the company’s website.
Bondia, developed by Solarea Bio, utilizes the proprietary MicroScape Technology to identify and optimize beneficial microbes found in fruits and vegetables. This approach harnesses the natural microbiome to provide clinically validated health benefits. The product represents a new option for individuals seeking dietary management of bone health concerns.
Bondia has undergone scientific evaluation, including a double-blind, placebo-controlled clinical trial with 286 women. The study demonstrated its ability to slow bone loss in a specific population. While results are pending peer review and publication, the findings support Bondia as a convenient and effective option for daily bone health management.
Ilissa Larimore, Chief Commercial Officer, highlighted the significance of Bondia’s clinical validation, stating that it provides a proactive option for managing bone health through scientifically backed methods.